Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Cancer treatment by combined inhibition of proteasome and telomerase activities

US Patent 7998938 · Granted Aug 16, 2011

Estimated economic value: $3,218,000

Assignee

Inventors

View full patent text on Google Patents →